Houston, TX, United States of America

William C Gundlach, Iv

This inventor holds 2 USPTO granted patents. Top assignee: Texas Heart Institute. Active years: 2016-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: William C Gundlach, Iv. Retrieved from https://idiyas.com/inventor/william-c-gundlach-iv

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2016-2019

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of William C Gundlach, IV

Introduction

William C Gundlach, IV is an accomplished inventor based in Houston, Texas. He has made significant contributions to the field of medical technology, particularly in the area of integrin-binding ligands. With a total of two patents to his name, Gundlach's work has the potential to impact therapeutic methods for various medical conditions.

Latest Patents

Gundlach's latest patents focus on agonists that enhance the binding of integrin-expressing cells to integrin receptors. The method involves treating integrin-expressing cells in vitro with an agonist of integrin, which is selected from a specific group of integrins. This process enhances the binding of cells to an integrin-binding ligand. The patents also describe integrin agonist compounds and therapeutic methods that involve administering agonist-treated cells or compounds to mammals.

Career Highlights

Gundlach is affiliated with the Texas Heart Institute, where he continues to innovate and develop new methods for enhancing cell binding. His work is crucial in advancing medical treatments that rely on integrin interactions.

Collaborations

Some of his notable coworkers include Ronald J Biediger and Robert V Market, who contribute to the collaborative efforts at the Texas Heart Institute.

Conclusion

William C Gundlach, IV is a notable inventor whose work in enhancing integrin-binding has the potential to revolutionize therapeutic approaches in medicine. His contributions reflect the importance of innovation in the healthcare sector.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…